Anton G. Gueth
Chief Executive Officer at Evolution Life Science Partners
Anton G. Gueth active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Gueth Consulting LLC | President | 2002-12-31 | - |
Evolution Life Science Partners
 Evolution Life Science Partners Investment ManagersFinance Evolution Life Science Partners is a life science investment bank that specializes in licensing, strategic advisory, M&A, and capital raising. The private company is based in San Francisco, CA. The CEOs are Anton G. Gueth, David C. Parke. The company was founded by Mary C. Tanner. | Chief Executive Officer | 2014-09-30 | - |
Career history of Anton G. Gueth
Former positions of Anton G. Gueth
| Companies | Position | Start | End |
|---|---|---|---|
| ANTARES PHARMA, INC. | Director/Board Member | 2003-09-30 | 2022-05-23 |
| Independent Dir/Board Member | 2003-09-30 | 2022-05-23 | |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 2015-06-03 | 2016-01-10 |
| Chairman | 2016-01-10 | 2016-03-30 | |
| Independent Dir/Board Member | 2015-06-03 | 2016-01-10 | |
| SPECTRUM PHARMACEUTICALS, INC. | Director/Board Member | 2012-06-30 | 2013-06-27 |
| Independent Dir/Board Member | 2012-06-30 | 2013-04-25 | |
iQone Healthcare Holding
 iQone Healthcare Holding Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., iQone Healthcare Holding provides pharmaceutical services. The company is based in Geneva, Switzerland. The Swiss company was founded in 1979. iQone Healthcare Holding was acquired by Clinigen Ltd., part of Triley Bidco Ltd. from April 04, 2022 on October 09, 2018 for $8.68 million. | Director/Board Member | 2012-06-30 | 2013-05-31 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | 2017-12-31 | - |
| Independent Dir/Board Member | 2017-12-31 | - | |
Eqinox Healthcare France SASU
 Eqinox Healthcare France SASU Pharmaceuticals: MajorHealth Technology Eqinox Healthcare France SASU provides pharmaceutical and health care services. The company was founded on January 9, 1989 and is headquartered in Toulouse, France. | Director/Board Member | 2015-09-30 | - |
| Eli Lilly Saudi Arabia Ltd. | Corporate Officer/Principal | - | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Anton G. Gueth
| University of Giessen | Graduate Degree |
| Indiana University | Graduate Degree |
Statistics
International
| United States | 12 |
| Germany | 2 |
| United Arab Emirates | 2 |
Operational
| Director/Board Member | 6 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 4 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 3 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
| PCS Health Systems, Inc. | Health Services |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates. | Health Technology |
| Gueth Consulting LLC | |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Commercial Services |
| Burrill Securities LLC | Finance |
Evolution Life Science Partners
Evolution Life Science Partners Investment ManagersFinance Evolution Life Science Partners is a life science investment bank that specializes in licensing, strategic advisory, M&A, and capital raising. The private company is based in San Francisco, CA. The CEOs are Anton G. Gueth, David C. Parke. The company was founded by Mary C. Tanner. | Finance |
| Eli Lilly Saudi Arabia Ltd. | |
Eqinox Healthcare France SASU
Eqinox Healthcare France SASU Pharmaceuticals: MajorHealth Technology Eqinox Healthcare France SASU provides pharmaceutical and health care services. The company was founded on January 9, 1989 and is headquartered in Toulouse, France. | Health Technology |
iQone Healthcare Holding
iQone Healthcare Holding Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., iQone Healthcare Holding provides pharmaceutical services. The company is based in Geneva, Switzerland. The Swiss company was founded in 1979. iQone Healthcare Holding was acquired by Clinigen Ltd., part of Triley Bidco Ltd. from April 04, 2022 on October 09, 2018 for $8.68 million. | Health Technology |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Anton G. Gueth
- Experience
